BioSpace News Archive

Veracyte, Inc. announced that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020 at 3:00 p.m. Eastern Time.

Molecular Templates, Inc. announced that the 2020 Annual Meeting of Stockholders will be held virtually due to the public health impact of the novel coronavirus outbreak and to support the health and well-being of the Company’s management and stockholders.

Atrion Corporation announced that revenues for the quarter ended March 31, 2020 were $43.6 million compared with $41.6 million for the same period in 2019.

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported its financial results for the first quarter ended March 31, 2020, and provided an update on clinical development programs.

Bexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company Orphan Drug Designation for its proprietary drug, BXQ-350, for the treatment of malignant glioma, including diffuse intrinsic pontine glioma (DIPG). DIPG primarily affects children, with most diagnoses occurring between 5 and 7 years of age

TARGET PharmaSolutions, an innovative healthcare data company that generates real-world clinical data and evidence, announced today the latest research findings from its inflammatory bowel disease study (TARGET-IBD), which was published in the May issue of the peer-reviewed journal Gastroenterology.

A patented surface-coating technology developed by Irish company Kastus® is shown to be effective against human coronavirus on treated surfaces, an independent Global testing laboratory has confirmed.

Apotex Corp. has reached a resolution with the U.S. Department of Justice (DOJ) Antitrust Division concerning the Department’s years long antitrust investigation into the U.S. generic drug industry.

Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced that management will present at the 2020 RBC Capital Markets Global Healthcare Conference to be held virtually on May 19-20.

Encouraging recent research finds susceptibility to developing a severe COVID-19 infection appears to be linked to vitamin D status.